Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
25 hedge funds and large institutions have $109K invested in Surgalign Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 15 closing their positions.
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
31% less funds holding
Funds holding: 36 → 25 (-11)
73% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 15
97% less capital invested
Capital invested by funds: $3.89M → $109K (-$3.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$92.6K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$76.7K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$46.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$46.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$26.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.09M |
| 2 |
AWS
Atria Wealth Solutions
New York
|
-$575K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$284K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$93K |
| 5 |
Renaissance Technologies
New York
|
-$85K |
SRGA Hedge Fund Activity: Q2 2023 in Review
25 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2023, worth a combined $109K — down 97% from $3.89M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of SRGA and 4 opened new positions — a net loss of 11 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $92.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.09M sold.
- 25 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2023, down from 36 in Q1 2023.
- Funds reported $109K of Surgalign Holdings, Inc. Common Stock stock for Q2 2023, down 97% quarter-over-quarter.
- 4 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2023 and 15 closed out, a net change of -11 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2023 was HRT Financial, an estimated $92.6K added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2023 was Armistice Capital, an estimated $2.09M sold.
Based on aggregated 13F filings for Q2 2023.